Xvivo Perfusion AB (XVIPF)

29.39 0.00 (0.00%) USD  |  OTCM  |  Jun 09, 16:00
More

Xvivo Perfusion EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for XVIPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Getinge AB Upgrade
Paxman AB Upgrade
Enovis Corp. Upgrade
Edwards Lifesciences Corp. Upgrade
IDEXX Laboratories, Inc. Upgrade